How to buy wetware

Most purchases of living material fail in one of three ways: the specification was too vague to compare quotes against, the licence did not permit the intended use, or the material arrived and nobody had agreed what would happen if it was wrong.

None of those are scientific problems. They are procurement problems, and they are avoidable with a process. This hub is that process.

The eight stages

Stage 1 — Define the deliverable

Write one sentence describing what arrives at your bench. Then check it against three questions.

Is it material, a service, or an object? Cells in a vial are material. A differentiation run is a service. A cast and matured tissue strip is an object. These are contracted differently, priced differently, and fail differently. The most common mismatch in this market is a buyer who needs an object and is sold material.

Who owns the maturation time? Neurons need weeks on an array before they do anything interesting. Muscle needs weeks of culture and stimulation before it produces useful force. If you buy a frozen vial, that time and its risk are yours. If you buy a delivered, matured product, they are the supplier’s. That transfer is most of what you are paying for when a finished product costs more than the cells inside it.

What is the acceptance test? If you cannot name a test and a threshold, you are not yet ready to buy. See stage 3.

Stage 2 — Decide buy or build

Buying is usually right, but not always, and the honest comparison includes more than reagents.

An in-house route costs: cells or a line, media and supplements, coating and consumables, technician hours at a real loaded rate, incubator and hood time, QC, and — the item most often omitted — the failure rate. A protocol that works four times in five has a 25 percent cost uplift hiding in it.

Against that, catalogue purchase costs the list price plus media, coating, shipping and, if you intend to sell anything downstream, a licence.

Two structural facts worth holding. First, volume changes the answer more than vendor choice does: in our recorded price data, a single supplier’s own price per million cells fell by roughly 46 percent between a one-million and a five-million vial. Before concluding a supplier is expensive, check you are comparing the same pack size. Second, for anything requiring a custom geometry there is a fixed tooling cost that is the same whether you order two units or twenty, which means small custom orders carry a per-unit price that is not representative of the part.

Stage 3 — Write the specification

This is where most of the value is won or lost, and it is covered in detail in what belongs in a wetware RFQ.

The four fields that most often decide whether two quotes are comparable:

• The counting convention. Total cells at freeze and viable cells post-thaw are different quantities. State which you mean.
• The delivery format. Frozen, plated live, cast into a device, or fixed.
• What is in scope. Media, supplements, coating, shipping, documentation.
• The acceptance criterion. A named test, a threshold, an instrument, a timepoint.

The acceptance criterion is what converts a purchase into a specification. Without it there is nothing to reject against, and the entire quality conversation at stage 8 becomes a matter of opinion.

Stage 4 — Identify suppliers

Two habits worth breaking.

Look outside the obvious category. The correct answer to a mechanical requirement is sometimes native tissue collected to a written specification, which is a normal commercial service, materially cheaper than anything engineered, and almost unknown to engineers. The correct answer to a geometry requirement is sometimes a stock device that is close enough, avoiding tooling cost entirely.

Ask whether the supplier will sell the object or only the data. A number of organisations with genuine capability to build what you want are structured to sell you a study rather than a part. That is a commercial question, not a technical one, and it is answered in the first email rather than after three weeks of scoping.

Stage 5 — Issue the RFQ and normalise

Send the same document to every supplier. Then, before comparing anything, put the responses on one basis:

1. Convert every price to the same unit and the same counting convention.
2. Add excluded items back in — a quote excluding media is not cheaper than one including it.
3. Separate non-recurring tooling from per-unit cost, and ask for the repeat-order price with tooling already amortised.
4. Note the grade. An RUO quote and a GMP quote are not comparable at all.
5. Note what each supplier declined to quote. That is often the most informative part of the response.

Stage 6 — Clear licensing and paperwork

Start this at stage 3, not here. It is listed sixth because that is where it usually happens, and that is the mistake.

Research use is granted as standard by essentially every supplier and repository. The right to provide a fee-for-service using the material, and the right to sell a product derived from it, generally are not — they are separately licensed and separately priced, and in some cases must be negotiated with an upstream depositing laboratory rather than with the party selling you the vial. Read cell line licensing for commercial use before you standardise a programme on a line.

Also running in parallel: donor consent restrictions, which can constrain sequencing; institutional MTA review; import permits, which are the importer’s responsibility and lead time; and biosafety approval for the containment level the material requires.

Stage 7 — Order and track

Three things to confirm on the purchase order rather than assume.

Lot reservation. Disease and reporter lines have lumpy, unadvertised availability. A line can be listed and still be months out. If you need a matched isogenic control, reserve both at once — they are stocked and priced separately and buyers routinely end up with a mutant and no control.

The production cadence. Living tissue often ships on a fixed weekly rhythm. One published example ships every Monday for Tuesday morning delivery, with a four-day shelf life that explicitly includes transit. You cannot accelerate a cadence like that; you can only plan against it.

The delivery day. Do not accept a Friday delivery of temperature-sensitive material into a building nobody enters until Monday. Vendors will generally hold to a requested ship date and almost never offer it unprompted.

See shipping live cells and tissue for format selection and the dangerous-goods treatment of each.

Stage 8 — Accept or reject

Do this the day it arrives.

Photograph the package before opening. Record the coolant state and read any temperature logger. Verify the lot against the certificate of analysis. Run a viability count by the vendor’s stated method. Seed an attachment control and count at 24 hours — that number predicts your experiment better than any figure on the datasheet.

Then raise any discrepancy inside the claim window, which is usually short, starts on delivery, and lives in the general terms rather than on the product page. Find it before the shipment arrives.

The fifteen things to have asked for by this point are in the cell supplier QC checklist.

Guides in this hub

• The QC data you should demand from any cell supplier — fifteen items, each with the acceptable specification, the red flag, and whether suppliers provide it as standard.
• Cell line licensing for commercial use — what research-use terms actually permit, quoted from published repository and vendor agreements, and why the right to sell a derivative is almost never included.
• Shipping live cells and tissue — four shipment formats compared on viability risk, cost, dangerous-goods treatment and acceptance testing.
• Realistic lead times for cells, tissue and custom devices — observed ranges across 26 offerings, the six drivers that actually set your date, and why a six-week quote becomes eleven.
• How to compare two custom biology quotes — the seventeen-line normalisation worksheet, plus two worked examples where the cheaper quote changes identity.
• Vials to wells: how many cells your experiment actually needs — published growth areas, sourced seeding densities, wells per vial, and the correction factors nobody puts on the datasheet.
• OECD TG 439: what a compliant RhE model must demonstrate — barrier function, MTT, controls, acceptance criteria, which models hold validation, and how TG 431 relates.
• What belongs in a wetware RFQ — the twenty-one-field checklist and a fully worked example.
• The wetware glossary — definitions for the terms used throughout.

Where we fit

We run stages 3 through 8 as a service. Send a specification in whatever state it is in, and we will turn it into a comparable RFQ, put it to named suppliers, normalise the responses onto one basis, and tell you where the quotes genuinely differ.

We are a facilitator. We do not manufacture, and we do not resell a particular supplier’s line, which is why we can tell you when the right answer is to make it yourself, to buy the cheaper adjacent thing, or to walk away from the line you had already chosen because the licence will not permit what you intend to do with it.